News Home

Should You Sell Oramed Pharmaceuticals, Inc. (ORMP) Stock Wednesday Morning?

Wednesday, November 24, 2021 07:13 AM | InvestorsObserver Analysts
Should You Sell Oramed Pharmaceuticals, Inc. (ORMP) Stock Wednesday Morning?

Oramed Pharmaceuticals, Inc. (ORMP) is up 4.34% today.

Overall Score - 58
ORMP has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on ORMP!
ORMP stock closed at $18.21 and is up $0.79 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ORMP has a roughly average overall score of 58 meaning the stock holds a better value than 58% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. ORMP gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Oramed Pharmaceuticals, Inc. currently has the 140th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders. Oramed Pharmaceuticals, Inc.'s Overall and Short-Term Technical score paint a mixed picture for ORMP's recent trading patterns and forecasted price. Click Here To Get The Full Report on Oramed Pharmaceuticals, Inc. (ORMP)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App